Home > Insider Trading > Filing (0001104659-25-021043)

Filing Details

Accession Number:: 0001104659-25-021043
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-05 19:53:31
Reporting Period:: 2025-03-03

Filing Date:: 2025-03-05
Accepted Time:: 2025-03-05 19:53:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1867066	Journey Medical Corp	DERM	Pharmaceutical Preparations (2834)	471879539

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1893880	Claude Maraoui	C/O Journey Medical Corporation 9237 E Via De Ventura Blvd., Suite 105 Scottsdale AZ 85258	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $0.0001 Par Value	Disposition	2025-03-03	23,508	$5.19	2,139,922	No	4	S	Direct
Common Stock, $0.0001 Par Value	Disposition	2025-03-04	28,901	$5.04	2,111,021	No	4	S	Direct
Common Stock, $0.0001 Par Value	Disposition	2025-03-05	18,147	$5.13	2,092,874	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

In connection with the vesting of restricted stock units which vested as of various dates, a total of 23,508 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units.
Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on March 3, 2025, was $5.00 to $5.57. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price.
Includes restricted stock units, which vest over various time periods.
In connection with the vesting of restricted stock units which vested as of various dates, a total of 28,901 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units.
Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on March 4, 2025, was $5.00 to $5.17. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price.
In connection with the vesting of restricted stock units which vested as of various dates, a total of 18,147 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units.
Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on March 5, 2025, was $5.02 to $5.26. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price.